SynthesisBMC cancer2025

Assessing first-line treatment for advanced EGFR-mutated NSCLC in diverse clinicopathological subgroups: a systematic review and network meta-analysis.

Ting Mei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.